# China NMPA Drug Inspection - Fujian Mindong Lijiexun Pharmaceutical Co., Ltd. - Sodium citicoline tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/fujian-mindong-lijiexun-pharmaceutical-co-ltd/db18af54-4d26-4bf8-b333-9e72969406c2/
Source feed: China

> China NMPA drug inspection for Fujian Mindong Lijiexun Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Sodium citicoline tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Fujian Mindong Lijiexun Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Sodium citicoline tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/fujian-mindong-lijiexun-pharmaceutical-co-ltd/f469c437-ec64-4cd4-b0f9-63aedd343555/